Related Experiment Videos
[Once-a-day highly active antiretroviral therapy. Present or future?]
Federico Pulido1, Asunción Hernando
1Unidad VIH, Servicio de Medicina Interna, Hospital Universitario 12 de Octubre, Madrid, España. fpulido@palmedico.com
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results From the VOLVER Clinical Trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Cost-effectiveness of cabotegravir versus tenofovir alafenamide plus emtricitabine versus tenofovir disoproxil fumarate plus emtricitabine for pre-exposure prophylaxis to prevent HIV-1 transmission in gay, bisexual and other men that have sex with men.
Enfermedades infecciosas y microbiologia clinica (English ed.)·2025
Foundations for the rational prescription of enteral medical nutrition therapy.
Medicina clinica·2026
Eating disorders.
Medicina clinica·2026
Women's Perspectives on Adjunct Therapies in IVF: Key Considerations and Influences.
The Australian & New Zealand journal of obstetrics & gynaecology·2026
Intratesticular varicocele: sonographic diagnosis and clinical impact.
Journal of ultrasonography·2026
Validating ovulation prediction and confirmation with the Mira monitor: blinded ultrasound and serum hormone comparison.
Reproductive biomedicine online·2026
Gamete selection in gay male surrogacy: Procreative labor beyond gestation.
Social science & medicine (1982)·2026
Intravenous intralipid therapy in recurrent implantation failure: Biological rationale, clinical evidence, and ongoing controversies.
Journal of gynecology obstetrics and human reproduction·2026